Scancell (LON:SCLP) Shares Cross Below 200-Day Moving Average of $15.44

Scancell Holdings plc (LON:SCLPGet Rating) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 15.44 ($0.19) and traded as low as GBX 14.13 ($0.17). Scancell shares last traded at GBX 14.75 ($0.18), with a volume of 721,468 shares trading hands.

The company has a market capitalization of £120.24 million and a PE ratio of -14.75. The company has a debt-to-equity ratio of 35.11, a quick ratio of 24.05 and a current ratio of 24.05. The business has a fifty day moving average price of GBX 13.95 and a 200 day moving average price of GBX 15.44.

About Scancell (LON:SCLP)

Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. The company's product candidates include SCIB1, which is in phase II clinical trial for the treatment of metastatic melanoma; SCIB2 for the treatment of non-small cell lung cancer; and Modi-1 that is in phase I/II clinical trials for the treatment of head and neck, triple negative breast, ovarian, and renal cancers.

Featured Stories

Want More Great Investing Ideas?

Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.